![Phillip Zamore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Phillip Zamore
Voorzitter bij
RNA Therapeutics Institute
Profiel
Phillip Zamore is the founder of Alnylam Pharmaceuticals, Inc., founded in 2002.
Dr. Zamore is the founder of Voyager Therapeutics, Inc., founded in 2013.
Dr. Zamore currently holds the position of Chairman at RNA Therapeutics Institute.
Dr. Zamore currently holds the position of Professor at UMass Chan Medical School.
Dr. Zamore completed undergraduate and doctorate degrees at Harvard University.
Actieve functies van Phillip Zamore
| Bedrijven | Functie | Begin |
|---|---|---|
UMass Chan Medical School
 UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
RNA Therapeutics Institute | Voorzitter | - |
Eerdere bekende functies van Phillip Zamore
| Bedrijven | Functie | Einde |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Oprichter | - |
| VOYAGER THERAPEUTICS, INC. | Oprichter | - |
Opleiding van Phillip Zamore
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
RNA Therapeutics Institute |
Kies MarketScreener 
